2MURRAY J B. Psychophysiological aspects of motion sickness[J]. Percept Mot Skills, 1997,85(3 pt 2):1163-1167.
3KODA-KIMBLE M A, YOUNG L Y, KRADJAN W A, et al.Applieed Therapeutics:the clinical use of drugs 8e[M]. LIPPINCOTT WILLIAMS & WOLKINS, 2005 : 8-5.
4李端,药理学第5版[M].人民卫生出版社,2003:275.
5BELLORINI J, CHAMBERLAIN J, BURTON M J. Antihistamines for motion sickness (Protocol)[J]. Cochrane Database Syst Rev,2008,23(2) :CD007164.
6WOOD C D. Antimotion sickness and antiemetic drugs [J]. Drugs, 1979,17(6) :471-479.
7BUCKEY J C, ALVARENGA D, COLE B, et al. Chlorpheniramine for motion sickness[J].J Vestib Res, 2004,14 (1) : 53-61.
8BUCKEY J C, ALVARENGA D L, MACKENZIE T A. Chlorpheniramine and ephedrine in combination for motion sickness[J]. J Vestib Res,2007,17(5-6) :301-11.
9WEINSTEIN S E, STERN R M. Comparison of marezine and dramamine in preventing symptoms of motion sickness[J].Aviat Space Environ Med, 1997,68(10) : 890-894.
10SPINKS A, WASIAK J, VILLANUEVA E, et al. Scopolamine (hyoscine) for preventing and treating motion sickness[J].Cocbrane Database Syst Rev,2007,18(3):CD002851.
